Semaglutide leads to greater weight reduction and higher HbA1c reductions, though it may have higher rates of gastrointestinal side effects Metformin vs semaglutide Metformin (generic) and semaglutide are effective for Type 2 diabetes and blood sugar control, but differ significantly: Metformin is an affordable daily oral pill usually prescribed first, while semaglutide is a once-weekly injection that generally yields superior weight loss (up to ~11%) and offers cardiovascular benefits
These products work by targeting pigment production, skin turnover, or both
Prioritize a rich variety of fiber, antioxidants, and vital nutrients by incorporating an array of fruits, vegetables, lean proteins, healthy fats, and whole grains into your meals
A 2021 safety review in Diabetes Therapy concluded that semaglutide typically causes mild to moderate gastrointestinal symptoms such as nausea and constipation, increases the risk of gallbladder disease like cholelithiasis, and has a generally favorable benefit-risk profile for people with type 2 diabetes, while long term risks of pancreatic or thyroid cancers remain uncertain because events are rare and follow up is limited
.png)
